Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome.

[1]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[2]  S. Emans,et al.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  A. Kunselman,et al.  Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. , 2001, The American journal of medicine.

[4]  C. Packard,et al.  Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters , 2001, Clinical endocrinology.

[5]  S. Arslanian,et al.  Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. , 2001, The Journal of clinical endocrinology and metabolism.

[6]  M. Malloy,et al.  A risk factor for atherosclerosis: triglyceride-rich lipoproteins. , 2001, Advances in internal medicine.

[7]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[8]  R. Lobo,et al.  The Importance of Diagnosing the Polycystic Ovary Syndrome , 2000, Annals of Internal Medicine.

[9]  M. Muggeo,et al.  Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. , 2000, The Journal of clinical endocrinology and metabolism.

[10]  C. Bogardus,et al.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. , 2000, American journal of epidemiology.

[11]  R. DeFronzo.  Pharmacologic Therapy for Type 2 Diabetes Mellitus , 1999, Annals of Internal Medicine.

[12]  A. Dunaif.  Insulin action in the polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.

[13]  R. Lobo,et al.  Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. , 1999, The Journal of clinical endocrinology and metabolism.

[14]  D. Langdon.  A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome , 1999 .

[15]  R. Lobo,et al.  Do hyperandrogenic women with normal menses have polycystic ovary syndrome? , 1999, Fertility and sterility.

[16]  W. Dodson,et al.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.

[17]  W A Hsueh,et al.  Cardiovascular risk continuum: implications of insulin resistance and diabetes. , 1998, The American journal of medicine.

[18]  D. Jakubowicz,et al.  Lean Women With Polycystic Ovary Syndrome Respond to Insulin Reduction With Decreases in Ovarian P450c17 alpha Activity and Serum Androgens , 1998 .

[19]  L. Kuller,et al.  Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. , 1998, Journal of clinical epidemiology.

[20]  J. Buring,et al.  Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. , 1997, Circulation.

[21]  D. Johnston,et al.  Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries , 1996, Clinical endocrinology.

[22]  M. Muggeo,et al.  The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. , 1996, The Journal of clinical endocrinology and metabolism.

[23]  V. Toscano,et al.  Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  T. Schwenk,et al.  Evaluation of amenorrhea. , 1996, American family physician.

[25]  H. Yki-Järvinen,et al.  Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. , 1995, The Journal of clinical endocrinology and metabolism.

[26]  J. Aloi.  Evaluation of amenorrhea. , 1995, Comprehensive therapy.

[27]  R. Azziz,et al.  Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. , 1994, The Journal of clinical endocrinology and metabolism.

[28]  P. Janson,et al.  Polycystic ovary syndrome — long‐term metabolic consequences , 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[29]  R. Legro,et al.  Polycystic ovary syndrome. , 1992, Current therapy in endocrinology and metabolism.

[30]  G. Conway,et al.  Risk Factors for Coronary Artery Disease in Lean and Obese Women With Polycystic Ovary Syndrome , 1993 .

[31]  S. Johansson,et al.  Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women , 1992, Acta obstetricia et gynecologica Scandinavica.

[32]  P. Bennett,et al.  A two-step model for development of non-insulin-dependent diabetes. , 1991, The American journal of medicine.

[33]  K. Segal,et al.  Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.

[34]  A. Kissebah,et al.  The relationship of insulin to sex hormone-binding globulin: role of adiposity. , 1989, Fertility and sterility.

[35]  A. Dunaif,et al.  Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. , 1987, The Journal of clinical endocrinology and metabolism.

[36]  R. Barbieri,et al.  Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. , 1986, The Journal of clinical endocrinology and metabolism.

[37]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[38]  S. Taylor,et al.  Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. , 1982, Annals of internal medicine.

[39]  A. Kitabchi,et al.  Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. , 1981, The Journal of clinical endocrinology and metabolism.